Ignite Creation Date:
2024-05-05 @ 11:20 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00003327
Status:
UNKNOWN
Last Update Posted:
2008-07-24
First Post:
1999-11-01
Brief Title:
Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer
Sponsor:
Theradex
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Head and Neck Cancer |
Keywords:
| Name | View |
|---|---|
| recurrent oropharyngeal cancer | View |
| stage IV nasopharyngeal cancer | View |
| recurrent nasopharyngeal cancer | View |
| stage IV lip and oral cavity cancer | View |
| recurrent lip and oral cavity cancer | View |
| stage IV hypopharyngeal cancer | View |
| recurrent hypopharyngeal cancer | View |
| stage IV laryngeal cancer | View |
| recurrent laryngeal cancer | View |
| stage IV paranasal sinus and nasal cavity cancer | View |
| recurrent paranasal sinus and nasal cavity cancer | View |
| stage IV oropharyngeal cancer | View |